• Micropelt

  Participated · Equity · May 2012

  Micropelt develops and produces thin-film thermoelectric microchips that scavenge waste heat to generate electricity and replace or recharge batteries in wireless sensor networks and micro actuators. The microchip-sized devices target cleantech markets with applications in radiator valves, industrial automation and remote equipment monitors, and the company partners with semiconductor players and system integrators. Micropelt opened a thin-film thermoelectric production facility in June 2011 in Halle, Germany and employs 23 staff. The company has agreed distribution relationships with Arrow in Europe and Tokyo Electronic Device and Hitachi High‑Tech Materials in Japan to support commercialisation. Micropelt raised €6.5M to support market roll-out and global expansion, with funds intended to boost production capacity, increase volumes and reduce per-unit cost. Investors in the round include Ludgate Environmental Fund, Mitsubishi UFJ Capital, and existing shareholders IBG/Goodvent, KfW, L‑Bank and SHS.

• Vivoryon Therapeutics

  Participated · Equity · Jan 2012

  Vivoryon Therapeutics is a therapeutics company; the article does not elaborate on its specific drug programs or markets. The company recently completed a capital raise through a private placement, securing what the article characterizes only as “millions.” This influx of capital is expected to bolster its balance sheet and finance ongoing operations and development work. No details were provided regarding revenue, user metrics, or commercial milestones. The report also omits information on the company’s valuation or cash runway prior to the transaction. Overall, the article focuses almost exclusively on the fact that the firm has raised additional funds.

No current team members are available.